Pharmacology of HIV integrase inhibitors

Authors
Publication date
1 January 2012
Publisher
Doi
    View on PubMed

    Abstract

    The purpose of this paper is to review recent and relevant pharmacology data for three HIV integrase inhibitors: raltegravir (marketed), dolutegravir and elvitegravir (both in Phase III drug development)

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Carolina Digital Repository

      redirect
      oaicdr.lib.unc.edu:d791sp52t
      Last time updated on 24/11/2020